MCK241101P340000
- 0.16
- 0.000.00%
McKesson Newsroom
McKesson, Cardinal Health Draw Ire of Sen. Warren Over Cancer Deals
How Is The Market Feeling About McKesson?
Barclays Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $616
McKesson (MCK) Beats Stock Market Upswing: What Investors Need to Know
Do Options Traders Know Something About McKesson (MCK) Stock We Don't?
Is McKesson Corporation (NYSE:MCK) the Most Undervalued Value Stock to Buy According to Analysts?
McCormick Establishes Growth Plans for Next 5 Years
Those Who Invested in McKesson (NYSE:MCK) Five Years Ago Are up 251%
McKesson's Quarterly Earnings Preview: What You Need to Know
Analysts Conflicted on These Healthcare Names: Medpace Holdings (MEDP), McKesson (MCK) and Glaukos (GKOS)
BofA Securities Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $635
McKesson (MCK) Stock Moves -0.17%: What You Should Know
With 88% Ownership, McKesson Corporation (NYSE:MCK) Boasts of Strong Institutional Backing
Express News | Mckesson: Ontada Collaborates With Microsoft to Transform Unstructured Oncology Data With Azure OpenAI Technology
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
Morgan Stanley Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $612
Morgan Stanley Keeps Their Buy Rating on McKesson (MCK)
Here's How The Post-COVID Market Normalization Affected McKesson Corporation (MCK)
TD Cowen Adjusts McKesson Price Target to $642 From $652
High Dividend Growth + High Free Cash Flow Yield Stocks = a Winning Strategy